Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clairafly study of BI 1291583 in adults with cystic fibrosis bronchiectasis
NL-OMON60504Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of verducatib, sponsored by Boehringer Ingelheim. Started Mar 2024; status: completed.
02
Drugs
verducatib
Beyond the preview
Go deeper on NL-OMON60504.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60504.